Šalis: Australija
kalba: anglų
Šaltinis: APVMA (Australian Pesticides and Veterinary Medicines Authority)
CEPHALEXIN AS CEPHALEXIN MONOHYDRATE
VIRBAC (AUSTRALIA) PTY LTD
cephalexin as monohydrate(300mg/Tb)
ORAL TABLET
CEPHALEXIN AS CEPHALEXIN MONOHYDRATE ANTIBIOTIC Active 300.0 mg/Tb
252 Tabs
VM - Veterinary Medicine
DOG | BITCH | CASTRATE | PUPPY
ANTIBIOTIC & RELATED
ENTEROBACTER SPP. | ESCHERICHIA COLI (E. COLI) | INFECTIONS OF SOFT CUTANEOUS TISSUE | INFECTIONS OF THE DIGESTIVE TRACT | INFECTIONS OF THE RESPIRATORY TRACT | INFECTIONS OF THE URINARY TRACTS | KLEBSIELLA SPP. | OSTEOMYELITIS | PROTEUS SPP. | SALMONELLA | SHIGELLA SPP. | STAPHYLOCOCCUS AUREUS | ACUTE RESPIRATORY INFECTIONS | BRONCHISEPTICA | BRONCHITIS | ESCHERICHIA COLI | GROUP D STREPTOCOCCUS | INCLUDING B-LACTAMASE PRODUCIN | KLEBSIELLA SPP. | PHARYNGITIS | PNEUMONIA | PROTEUS SPP. | PSEUDOMONAS AERUGINOSA | SALMONELLOSIS | STAPHYLOCOCCUS SPP. | TONSILLITIS
Poison schedule: 4; Withholding period: WHP: N/A; Host/pest details: DOG: [ENTEROBACTER SPP., ESCHERICHIA COLI (E. COLI), INFECTIONS OF SOFT CUTANEOUS TISSUE, INFECTIONS OF THE DIGESTIVE TRACT, INFECTIONS OF THE RESPIRATORY TRACT, INFECTIONS OF THE URINARY TRACTS, KLEBSIELLA SPP., OSTEOMYELITIS, PROTEUS SPP., SALMONELLA, SHIGELLA SPP., STAPHYLOCOCCUS AUREUS]; Poison schedule: 4; Withholding period: ; Host/pest details: DOG: [ENTEROBACTER SPP., ESCHERICHIA COLI (E. COLI), INFECTIONS OF SOFT CUTANEOUS TISSUE, INFECTIONS OF THE DIGESTIVE TRACT, INFECTIONS OF THE RESPIRATORY TRACT, INFECTIONS OF THE URINARY TRACTS, KLEBSIELLA SPP., OSTEOMYELITIS, PROTEUS SPP., SALMONELLA, SHIGELLA SPP., STAPHYLOCOCCUS AUREUS]; For treatment of bacterial infections susceptible to cephalexin.DO NOT use in animals that are hypersensitive to cephalosporins & other penicillins. Some dogs may exhibit nausea, vomiting & diarrhoea.
Registered
2023-07-01
INFOPEST VERIFIES THAT THIS LABEL IS CONSISTENT WITH THE NRA APPROVED TEXT LABEL OF 27/3/97 ________ DRAFT LABEL (FRONT PANEL) PRESCRIPTION ANIMAL REMEDY KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY _RILEXINE 300_ CEPHALEXIN ANTIBIOTIC TABLETS FOR DOGS ACTIVE CONSTITUENT: Each tablet contains: 300mg CEPHALEXIN (as MONOHYDRATE) FOR TREATMENT OF BACTERIAL INFECTIONS SUSCEPTIBLE TO CEPHALEXIN • INFECTIONS OF SOFT CUTANEOUS TISSUE • RESPIRATORY AND DIGESTIVE INFECTIONS • URINARY INFECTIONS • PREVENTION AND TREATMENT OF OSTEOMYELITIS 252 TABLETS (42 FOIL PACKS OF 6 TABLETS WITH DISPENSING ENVELOPES) Back Panel DIRECTIONS FOR USE: THIS PRODUCT IS CONTRAINDICATED IN ANIMALS THAT ARE HYPERSENSITIVE TO CEPHALOSPORINS AND OTHER PENICILLINS. SIDE EFFECTS: Some dogs may exhibit nausea, vomiting and diarrhoea. DOSAGE AND ADMINISTRATION DOGS: 30mg/kg/day at 12 hourly intervals (i.e. 1 tablet per 20kg bodyweight morning and night). In refractory cases, dose may be increased to 40mg/kg/day at 12 hourly intervals (i.e. 1 tablet per 15kg bodyweight morning and night). Treatment should be carried out for at least 3 days at discretion of Veterinarian. Is active against certain strains of Penicillinases producing _Staphylococcus _ _aureus._ Effective against susceptible_ _ _E.coli, _ _Klebsiella, _ _Proteus, _ _Salmonella, _ _Shigella _ _and_ _Enterobacter._ VIRBAC AUSTRALIA PTY. LIMITED 15 Pritchard Place, Peakhurst NSW 2210 DISPOSAL: Dispose of empty container by wrapping with paper and putting in garbage. S S T T O O R R A A G G E E : : Store below 30 º C (Room Temperature). Registered Trade Mark of Virbac. [B]: CODE: 9262 B EXP: NRA: 40380/01 11.10.96 Draft Label (Blister Foil Pack) PRESCRIPTION ANIMAL REMEDY KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY _RILEXINE_ 300 CEPHALEXIN ANTIBIOTIC TABLETS FOR DOGS ACTIVE CONSTITUENT: 300mg CEPHALEXIN (as MONOHYDRATE) per tablet [B] EXP: Space Required 22mm x 22mm Perskaitykite visą dokumentą
VIRBAC (AUSTRALIA) PTY. LTD. DOCUMENT NO: RILEXINE CEPHALEXIN TABLETS REVISION C MATERIAL SAFETY DATA SHEET Product Name: Rilexine Cephalexin Antibiotic Tablets for Dogs and Cats PAGE: 1 OF 4 DATE OF ISSUE 17 SEPTEMBER, 2008 EMERGENCY: VIRBAC: 02 9772 9772 OR 1800 242 100 (BUSINESS HOURS ONLY) POISONS INFORMATION CENTRE: 13 1126 FROM ANYWHERE IN AUSTRALIA, (0800 764 766 IN NEW ZEALAND) SECTION 1 - IDENTIFICATION OF CHEMICAL PRODUCT AND COMPANY COMPANY: VIRBAC (AUSTRALIA) PTY. LTD ABN 77 003 268 871 ADDRESS 361 Horsley Rd, Milperra, NSW 2214, Australia Locked Bag 6000, Milperra Business Centre, NSW 1891, Australia TELEPHONE: (02) 9772 9772 or 1800 242 100 FAX: (02) 9772 9773 EMERGENCY PHONE As above during business hours; answering machine after hours SUBSTANCE: Cephalexin is an antibiotic TRADE NAME: Rilexine Cephalexin Antibiotic Tablets for Dogs and Cats APVMA CODE: 40379: Rilexine 75 Cephalexin Antibiotic Tablets For Dogs And Cats 40380: Rilexine 300 Cephalexin Antibiotic Tablets For Dogs And Cats PRODUCT USE: For the treatment in dogs and cats of bacterial infections susceptible to Cephalexin. CREATION DATE: JUNE, 2002 REVISION DATE: JANUARY, 2008 SECTION 2 - HAZARDS IDENTIFICATION STATEMENT OF HAZARDOUS NATURE This product is classified as: Not classified as hazardous according to the criteria of ASCC Australia. Not a Dangerous Good according to the Australian Dangerous Goods (ADG) Code. RISK PHRASES: Not Hazardous - No criteria found. SAFETY PHRASES: Not Hazardous - No criteria found. SUSDP CLASSIFICATION: S4 ADG CLASSIFICATION: None allocated. Not a Dangerous Good. UN NUMBER: None allocated EMERGENCY OVERVIEW PHYSICAL DESCRIPTION & COLOUR : White to off-white tablets (some are scored). ODOUR: No data. MAJOR HEALTH HAZARDS: No major health hazards are known. POTENTIAL HEALTH EFFECTS INHALATION SHORT TERM EXPOSURE: This product may be irritating, but is unlikely to cause anything more than mild transient discomfort. LONG TERM EXPOSURE: No data for health effects associated with long term inhalation. SKIN CON Perskaitykite visą dokumentą